Quantifying CO2 Insertion Equilibria for Low-Pressure Propene Oxide and Carbon Dioxide Ring Opening Copolymerization Catalysts.

While outstanding catalysts are known for the ring-opening copolymerization (ROCOP) of CO2 and propene oxide (PO), few are reported at low CO2 pressure. Here, a new series of Co(III)M(I) heterodinuclear catalysts are compared. The Co(III)K(I) complex shows the best activity (TOF = 1728 h-1) and selectivity (>90% polymer, >99% CO2) and is highly effective at low pressures (<10 bar). CO2 insertion is a prerate determining chemical equilibrium step. At low pressures, the concentration of the active catalyst depends on CO2 pressure; above 12 bar, its concentration is saturated, and rates are independent of pressure, allowing the equilibrium constant to be quantified for the first time (Keq = 1.27 M-1). A unified rate law, applicable under all operating conditions, is presented. As proof of potential, published data for leading literature catalysts are reinterpreted and the CO2 equilibrium constants estimated, showing that this unified rate law applies to other systems.

Al(III)/K(I) Heterodinuclear Polymerization Catalysts Showing Fast Rates and High Selectivity for Polyester Polyols.

Low molar mass, hydroxyl end-capped polymers, often termed "polyols," are widely used to make polyurethanes, resins, and coatings and as surfactants in liquid formulations. Epoxide/anhydride ring-opening copolymerization (ROCOP) is a controlled polymerization route to make them, and its viability depends upon catalyst selection. In the catalysis, the polyester polyol molar masses and end-groups are controlled by adding specific but excess quantities of diols (vs catalyst), known as the chain transfer agent (CTA), to the polymerizations, but many of the best current catalysts are inhibited or even deactivated by alcohols. Herein, a series of air-stable Al(III)/K(I) heterodinuclear polymerization catalysts show rates and selectivity at the upper end of the field. They also show remarkable increases in activity, with good selectivity and control, as quantities of diol are increased from 10-400 equiv. The reactions are accelerated by alcohols, and simultaneously, their use allows for the production of hydroxy telechelic poly/oligoesters (400 < Mn (g mol-1) < 20,400, D < 1.19). For example, cyclohexene oxide (CHO)/phthalic anhydride (PA) ROCOP, using the best Al(III)/K(I) catalyst with 200 equiv of diol, shows a turnover frequency (TOF) of 1890 h-1, which is 4.4× higher than equivalent reactions without any diol (Catalyst/Diol/PA/CHO = 1:10-400:400:2000, 100 °C). In all cases, the catalysis is well controlled and highly ester linkage selective (ester linkages >99%) and operates effectively using bicyclic and/or biobased anhydrides with bicyclic or flexible alkylene epoxides. These catalysts are recommended for future production and application development using polyester polyols.

Understanding catalytic synergy in dinuclear polymerization catalysts for sustainable polymers.

Understanding the chemistry underpinning intermetallic synergy and the discovery of generally applicable structure-performances relationships are major challenges in catalysis. Additionally, high-performance catalysts using earth-abundant, non-toxic and inexpensive elements must be prioritised. Here, a series of heterodinuclear catalysts of the form Co(III)M(I/II), where M(I/II) = Na(I), K(I), Ca(II), Sr(II), Ba(II) are evaluated for three different polymerizations, by assessment of rate constants, turn over frequencies, polymer selectivity and control. This allows for comparisons of performances both within and between catalysts containing Group I and II metals for CO2/propene oxide ring-opening copolymerization (ROCOP), propene oxide/phthalic anhydride ROCOP and lactide ring-opening polymerization (ROP). The data reveal new structure-performance correlations that apply across all the different polymerizations: catalysts featuring s-block metals of lower Lewis acidity show higher rates and selectivity. The epoxide/heterocumulene ROCOPs both show exponential activity increases (vs. Lewis acidity, measured by the pKa of [M(OH2)m]n+), whilst the lactide ROP activity and CO2/epoxide selectivity show linear increases. Such clear structure-activity/selectivity correlations are very unusual, yet are fully rationalised by the polymerization mechanisms and the chemistry of the catalytic intermediates. The general applicability across three different polymerizations is significant for future exploitation of catalytic synergy and provides a framework to improve other catalysts.

Synergic Heterodinuclear Catalysts for the Ring-Opening Copolymerization (ROCOP) of Epoxides, Carbon Dioxide, and Anhydrides.

The development of sustainable plastic materials is an essential target of chemistry in the 21st century. Key objectives toward this goal include utilizing sustainable monomers and the development of polymers that can be chemically recycled/degraded. Polycarbonates synthesized from the ring-opening copolymerization (ROCOP) of epoxides and CO2, and polyesters synthesized from the ROCOP of epoxides and anhydrides, meet these criteria. Despite this, designing efficient catalysts for these processes remains challenging. Typical issues include the requirement for high catalyst loading; low catalytic activities in comparison with other commercialized polymerizations; and the requirement of costly, toxic cocatalysts. The development of efficient catalysts for both types of ROCOP is highly desirable. This Account details our work on the development of catalysts for these two related polymerizations and, in particular, focuses on dinuclear complexes, which are typically applied without any cocatalyst. We have developed mechanistic hypotheses in tandem with our catalysts, and throughout the Account, we describe the kinetic, computational, and structure-activity studies that underpin the performance of these catalysts. Our initial research on homodinuclear M(II)M(II) complexes for cyclohexene oxide (CHO)/CO2 ROCOP provided data to support a chain shuttling catalytic mechanism, which implied different roles for the two metals in the catalysis. This mechanistic hypothesis inspired the development of mixed-metal, heterodinuclear catalysts. The first of this class of catalysts was a heterodinuclear Zn(II)Mg(II) complex, which showed higher rates than either of the homodinuclear [Zn(II)Zn(II) and Mg(II)Mg(II)] analogues for CHO/CO2 ROCOP. Expanding on this finding, we subsequently developed a Co(II)Mg(II) complex that showed field leading rates for CHO/CO2 ROCOP and allowed for unique insight into the role of the two metals in this complex, where it was established that the Mg(II) center reduced transition state entropy and the Co(II) center reduced transition state enthalpy. Following these discoveries, we subsequently developed a range of heterodinuclear M(III)M(I) catalysts that were capable of catalyzing a broad range of copolymerizations, including the ring-opening copolymerization of CHO/CO2, propylene oxide (PO)/CO2, and CHO/phthalic anhydride (PA). Catalysts featuring Co(III)K(I) and Al(III)K(I) were found to be exceptionally effective for PO/CO2 and CHO/PA ROCOP, respectively. Such M(III)M(I) complexes operate through a dinuclear metalate mechanism, where the M(III) binds and activates monomers while the M(I) species binds the polymer change in close proximity to allow for insertion into the activated monomer. Our research illustrates how careful catalyst design can yield highly efficient systems and how the development of mechanistic understanding aids this process. Avenues of future research are also discussed, including the applicability of these heterodinuclear catalysts in the synthesis of sustainable materials.

Retroviral microarray-based platform on nanostructured TiO2 for functional genomics and drug discovery.

Living-cell microarrays are powerful tools for functional genomics and drug discovery. However, despite several attempts to improve this technology, it is still a challenge to obtain microarrays of cells efficiently overexpressing or downregulating specific genes to address complex phenotypes. Here, we present a cell-based microarray for phenotype screening on primary and cancer cells based on the localized reverse infection by retroviruses. Viral vectors are immobilized on a nanostructured titanium dioxide (ns-TiO2) film obtained by depositing a supersonic beam of titania clusters on a glass substrate. We validated the retroviral cell array by overexpression of GFP reporter genes in primary and cancer cells, and by RNA interference of p53 in primary cells by analyzing effects in cell growth. We demonstrate that ns-TiO2 retroviral arrays are an enabling tool for the study of gene function of families of genes for complex phenotypes and for the identification of novel drug targets.

Biocompatibility of cluster-assembled nanostructured TiO2 with primary and cancer cells.

We have characterized the biocompatibility of nanostructured TiO2 films produced by the deposition of a supersonic beam of TiOx clusters. Physical analysis shows that these films possess, at the nanoscale, a granularity and porosity mimicking those of typical extracellular matrix structures and adsorption properties that could allow surface functionalization with different macromolecules such as DNA, proteins, and peptides. To explore the biocompatibility of this novel nanostructured surface, different cancer and primary cells were analyzed in terms of morphological appearance (by bright field microscopy and immunofluorescence) and growth properties, with the aim to evaluate cluster-assembled TiO2 films as substrates for cell-based and tissue-based applications. Our results strongly suggest that this new biomaterial supports normal growth and adhesion of primary and cancer cells with no need for coating with ECM proteins; we thus propose this new material as an optimal substrate for different applications in cell-based assays, biosensors or microfabricated medical devices.

A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumors.

PURPOSE: This study was performed to determine the maximum tolerated dose, dose-limiting toxicities, and pharmacokinetics of brostallicin, a nonalkylating DNA minor groove binder and a synthetic derivative of distamycin A, given as a weekly i.v. infusion. EXPERIMENTAL DESIGN: Using an accelerated dose escalation design, patients with advanced solid tumor malignancies were treated with brostallicin administered as a 10-min i.v. infusion on days 1, 8, and 15 of a 28-day cycle. The starting dose of brostallicin was 0.3 mg/m(2)/week. To study the pharmacokinetic behavior of brostallicin, serial blood samples were obtained before and after the first and last infusions during cycle 1, and in cycles 2 and 4 in a limited number of patients. RESULTS: Fourteen patients received 32 complete cycles of brostallicin. Dose-limiting toxicity was febrile neutropenia and was observed in 3 of 5 patients treated at 4.8 mg/m(2)/week. The maximum tolerated dose and recommended Phase II dose was 2.4 mg/m(2)/week. The mean +/- SD terminal half-life at the maximum tolerated dose was 4.6 +/- 4.1 h. There was moderate distribution of brostallicin into tissues, and the clearance was approximately 20% of the hepatic blood flow. The area under the concentration time curve(0- infinity ) of brostallicin increased in a dose-linear fashion. No significant relationship was observed between any plasma pharmacokinetic parameter and clinical toxicities. There were no objective responses during the trial, but 5 patients had stable disease after two cycles of treatment. CONCLUSIONS: The dose-limiting toxicity of weekly brostallicin was neutropenia. Systemic exposure increases linearly with dose. The recommended dose for Phase II studies is 2.4 mg/m(2) on days 1, 8, and 15 of a 28-day cycle.